Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00RJB
|
||||
Former ID |
DIB014546
|
||||
Drug Name |
Rilopirox
|
||||
Synonyms |
Riloprox; Hoe-351
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Fungal infections [ICD9: 110-118; ICD10:B35-B49] | Phase 2 | [1] | ||
Company |
Hoechst AG
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H16ClNO4
|
||||
Canonical SMILES |
n1(c(cc(cc1=O)C)COc1ccc(Oc2ccc(Cl)cc2)cc1)O
|
||||
CAS Number |
CAS 104153-37-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Arachidonate 5-lipoxygenase | Target Info | Inhibitor | [2] | |
BioCyc Pathway | Aspirin-triggered lipoxin biosynthesis | ||||
Resolvin D biosynthesis | |||||
Leukotriene biosynthesis | |||||
Lipoxin biosynthesis | |||||
Aspirin triggered resolvin D biosynthesis | |||||
Aspirin triggered resolvin E biosynthesis | |||||
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Toxoplasmosis | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Vitamin D Receptor Pathway | ||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient Network | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006112) | ||||
REF 2 | Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect. Mycoses. 1991;34 Suppl 1:91-3. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.